What is Neurocrine Biosciences's share buybacks?

Neurocrine Biosciences (NBIX) reported share buybacks of $54M in Q1 2026.

How has Neurocrine Biosciences's share buybacks changed year-over-year?

Neurocrine Biosciences's share buybacks decreased by 64.0% year-over-year, from $150M to $54M.

What does share buybacks mean?

Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Neurocrine Biosciences NBIX Share Buybacks

Share Buybacks at other companies

BridgeBio PharmaBBIO

$82.5M+70.9%

AlkermesALKS

$27.7M—

TG TherapeuticsTGTX

$99.99M+1,533%

Rigel PharmaceuticalsRIGL

$3.74M—

Other financials

Income statement

See full

Revenue$814.5M+42.2%

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$18.18B+34.3%

Enterprise value$18.37B+33.6%

P/E27.2×-11.7×

P/S5.9×+0.5×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's share buybacks?: Neurocrine Biosciences (NBIX) reported share buybacks of $54M in Q1 2026.
How has Neurocrine Biosciences's share buybacks changed year-over-year?: Neurocrine Biosciences's share buybacks decreased by 64.0% year-over-year, from $150M to $54M.
What does share buybacks mean?: Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.